for patients and families. Severe edema can compromise healing, leading to suboptimal formation of scar tissue and significantly altering the intended morphologic result. Many surgeons have utilized steroids in an effort to decrease these postoperative morbidities. Goldman was the first to report their use in the English literature, in the early 1950s. 5 Since that time, there have been a number of investigations into the efficacy of different steroids, along with their various doses and schedules. [6] [7] [8] [9] [10] [11] [12] [13] Griffies et al were the first to undertake a prospective randomized study to examine the use of steroids in rhinoplasty. Comparing the effects of dexamethasone versus control in edema after rhinoplasty, the authors demonstrated that a one-time bolus of dexamethasone yielded a statistically significant reduction in swelling over the root of the nose. 6 Subsequently, Hoffmann et al demonstrated the superiority of one-time preoperative steroid administration in decreasing eyelid and paranasal edema in a prospective study of 49 patients undergoing rhinoplasty. 7 In 1998, Berinstein et al utilized magnetic resonance imaging and showed that the perioperative administration of dexamethasone yielded a statistically significant increase in swelling over the root of the nose. 8 The first prospective randomized trial investigating the efficacy of steroids in rhinoplasty patients was published by Kara et al in 1999 . In 55 consecutive patients, preoperative and postoperative administration of dexamethasone led to decreased edema in the upper and lower eyelids for the first two days postoperatively when compared to control. 9 Kargi et al examined dexamethasone and its effect on edema, ecchymosis, and intraoperative bleeding in rhinoplasty. 10 These authors were the first to examine extended dosing of steroids beyond the operation. They studied groups of patients receiving single preoperative doses, preoperative doses with extended dosing for 48 hours postoperatively, postoperative doses with extended dosing for 48 hours postoperatively, and a control group receiving nothing. All groups receiving steroids before osteotomies demonstrated decreased edema in the early postoperative period when compared to controls and patients receiving the initial dose postoperatively. Extended dosing to 48 hours postoperatively led to significantly decreased edema and ecchymosis on Postoperative Day (PD) 5 when compared to other groups. In 2006, Gurlek et al demonstrated no benefit in the reduction of edema and ecchymosis with perioperative dexamethasone or betamethasone in rhinoplasty patients.
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Their findings, along with the previously-mentioned results from Berinstein et al, confuse the picture surrounding the clinical efficacy of steroids in rhinoplasty.
Prospective randomized investigations have also assessed the efficacy of methylprednisone as compared to arnica and no treatment. 12 In 48 consecutive patients, there was a statistically significant increase in the amount of edema immediately postoperatively in the control group as compared to the patients who received arnica and those who received steroids. No difference was found between the methylprednisone group and the arnica group. Because of the controversy surrounding the efficacy of steroids in rhinoplasty patients, Gurlek et al undertook a prospective randomized investigation to compare high-dose methylprednisolone (500 mg) with 250-mg doses and control. 13 The study demonstrated a statistically significant benefit to administering steroids versus control in terms of edema. There was no difference between the steroid dose groups.
Because these studies were prospective randomized trials, the collective data gathered through these efforts lend themselves to meta-analysis. In an effort to pool these data and make a stronger conclusion regarding the efficacy of steroids on edema reduction in rhinoplasty, a systematic literature review was designed. Subsequently, a meta-analysis of the relevant data was performed. Our goal was to gain a greater understanding of the role of steroids for the rhinoplasty patient and their potential to reduce ecchymosis and edema. We also wished to establish evidence-based treatment guidelines for successful steroid administration. 
MEthOds

Literature Review
Article Selection
The selection of appropriate data from existing articles was organized in a two-step fashion. First, prospective randomized trials evaluating the efficacy of steroid treatment for minimization of postoperative edema and ecchymosis were identified. Second, the articles were thoroughly examined, and those whose authors utilized a comparable method of quantifying edema and ecchymosis of the upper and lower eyelids were included in the analysis so that the data could be accurately pooled and statistically compared.
Data Collection and Statistical Analysis
Relevant data were extracted from the chosen articles, including which intervention was given to which group, the total number of patients in each group, the upper and lower eyelid edema ratings, and the upper and lower eyelid ecchymosis ratings for each time point. Different categories of outcomes were examined: upper eyelid edema, lower eyelid edema, upper eyelid ecchymosis, lower eyelid ecchymosis, intraoperative bleeding, postoperative pain/discomfort, and analgesics. Categories of intervention were also assessed.
Patients receiving steroids and patients receiving no steroids were both examined globally; steroids for patients receiving them were then broken down by type, timing of administration, dosage, and length of treatment.
Upon review of the relevant data, three tests were devised: Test 1, a global examination of edema and ecchymosis seen in all groups receiving steroids of any sort versus all controls; Test 2, a comparison of edema and ecchymosis seen in groups receiving preoperative versus postoperative steroids; and Test 3, an examination of edema and ecchymosis seen in groups receiving one dose versus extended dosing. None of the articles provided patient-specific numbers; rather, the results were reported by group means. These means were extracted and multiplied by their respective group total to provide a group sum. These sums were then added where relevant and divided by the total group number for that respective intervention, group, and so on.
Test 1: Steroid Versus Control Group Calculations
Mean edema and ecchymosis scores for all patient groups receiving steroids and all patient control groups were multiplied by their respective group numbers to calculate total group scores. These were added and then divided by the respective total group number to calculate means and standard deviations for the groups-specifically, for upper eyelid edema scores, lower eyelid edema scores, upper eyelid ecchymosis scores, and lower eyelid ecchymosis scores on PD 1, 4, and 7. Statistical analysis was carried out on the pertinent data utilizing standard χ 2 nonparametric comparisons.
Test 2: Preoperative Initial Dose Versus Postoperative Initial Dose Calculations
Mean edema and ecchymosis scores for all patient groups who received their first dose of steroids preoperatively or at induction and all patient groups who received their first dose of steroids postoperatively were multiplied by their respective group numbers to calculate total group scores. These were added and then divided by the total group number to calculate means and standard deviations for the respective groups-namely, for upper eyelid edema scores, lower eyelid edema scores, upper eyelid ecchymosis scores, and lower eyelid ecchymosis scores on PD 1 and 7. Statistical analysis was carried out on the pertinent data utilizing standard χ 2 nonparametric comparisons.
Test 3: Single Dose Versus Extended Postoperative Dosing Calculations
Mean edema and ecchymosis scores for all patient groups who received one-dose steroids and all patient groups who received extended steroid dosing were multiplied by their respective group numbers to calculate total group scores. These were added and then divided by the total group number to calculate means and standard deviations for the respective groups-again, for upper eyelid edema scores, lower eyelid edema scores, upper eyelid ecchymosis scores, and lower eyelid ecchymosis scores on PD 1 and 7. Statistical analysis was carried out on the pertinent data utilizing standard χ 2 nonparametric comparisons.
REsuLts
The initial search revealed 29 articles of interest. Four were not written in English and did not meet inclusion criteria. 14-17 Eleven were not included because their discussion of steroids was about the postoperative treatment of pollybeak or supratip deformity, complications of steroid use in rhinoplasty patients, global steroid administration in plastic surgical procedures, or the medical use of steroids in rhinoplasty. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Six discussed steroid use in rhinoplasty, but their data were excluded either because the articles were reviews or because the study designs were not randomized and prospective. [29] [30] [31] [32] [33] [34] Eight were prospective randomized trials investigating postoperative edema and ecchymosis in rhinoplasty patients. [6] [7] [8] [9] [10] [11] [12] [13] Upon closer investigation of these eight studies, seven utilized the same methods of quantifying postoperative edema and ecchymosis in the upper and lower eyelids, whereby eyelid edema was graded 0 if there was no edema, 1 if the edema was minimal, 2 if the edema extended onto the iris, 3 if the edema covered the iris, and 4 if the edema caused the eyelids to be swollen shut. Ecchymosis was graded 1 if it was only medial, 2 if it extended to the iris, 3 if the ecchymosis was lateral to the pupil, and 4 if it extended to the lateral canthus. [6] [7] [8] [9] [10] [11] 13 Three studies were not included in the meta-analysis because their scoring systems and outcomes evaluations were different and did not allow appropriate cross-evaluation. 6, 8, 11 This resulted in four prospective randomized studies that were felt to have comparable data (Table 1) . 7, [9] [10] [11] Test 1: Steroids Versus Control All groups from all four studies were included in the statistical analysis. In sum, 144 patients who received steroids and 60 patients who did not receive steroids had data from PD 1 and 7 amenable to analysis; furthermore, 62 patients treated with steroids and 42 control patients had data for analysis of PD 4 numbers. The mean upper eyelid edema severity on PD 1 (P < .0001), PD 4 (P = .0001), and PD 7 (P = .0002) was statistically decreased in patients who received steroids versus control patients, who received no treatment ( Figure 1 ; Table 2 ). Mean lower eyelid edema severity in patients receiving steroids was significantly decreased in comparison to control patients on PD 1 (P < .0001) and PD 7 (P = .0036). There was no statistically significant difference between the two groups for lower eyelid edema on PD 4 (P = .287) (Figure 2 ; Table  2 ). Upper eyelid ecchymosis was significantly decreased in patients who received steroids versus control. This pattern was observed in the statistical comparison of the groups on PD 1 (P < .0001) and PD 7 (P < .0001) ( Figure 3 ; Table  2 ). The same results were seen for ecchymosis in the lower eyelid on PD 1 (P < .0001) and PD 7 (P = .0002) ( Figure 4 ; Table 2 ).
Test 2: Preoperative Initial Dose Versus Postoperative Initial Dose
To compare preoperative steroid treatment to postoperative treatment, patients were identified who received their first dose of steroids preoperatively or at induction (n = 114) and who received their first dose of steroids postoperatively (n = 30). Data from PD 1 and 7 were amenable to analysis. The mean upper eyelid edema severity on PD 1 (P < .0001) was statistically decreased in patients who received steroids preoperatively or at induction versus patients who received their first dose postoperatively ( Figure 5 ; Table 3 ). No difference between the groups was found on PD 7 (P = .7074). Mean lower eyelid edema severity was decreased in patients who received steroids preoperatively or at induction versus patients who received their first dose on PD 1 (P < .02). There was no statistically significant difference between the two groups for lower eyelid edema on PD 7 (P = .4946) ( Figure 6 ; Table  3 ). Upper eyelid ecchymosis was significantly decreased in patients who received preoperative or induction first-dose steroids versus postoperative first-dose steroids. This was seen on both PD 1 (P < .0001) and PD 7 (P < .012) ( Figure 7 ; Table 3 ). No difference was found between the two groups when their lower eyelid ecchymosis was compared, on either PD 1 (P = .523) or PD 7 (P = .12) ( Figure  8 ; Table 3 ).
Test 3: Single Dose Versus Extended Postoperative Dosing
Some groups from all four studies were included in the statistical analysis. Control groups were not included, as they did not receive steroids. Because of the statistically significant results from Test 2, results from groups of patients who received their first dose of steroids postoperatively were not included, in an effort to maximize the reliability of the data. Fifty-four patients who received just one dose of steroids preoperatively and 60 patients who received extended dosing of steroids beyond their initial dose had data from PD 1 and 7 amenable to analysis. Mean upper eyelid edema severity on PD 1 (P < .0001) and PD 7 (P = .0017) was statistically decreased in patients who received extended dosing versus patients who received single doses ( Figure 9 ; Table 4 ). On PD 7 there was a statistically significant decrease in lower eyelid edema severity in patients who received extended dosing of steroids (P < .0001). This difference was not seen between the groups on PD 1 (P = .125) ( Figure 10 ; Table 4 ). Upper eyelid ecchymosis was decreased in patients who received extended dosing of steroids versus those who received a single dose of steroids. This was seen on both PD 1 (P < .002) and PD 7 (P < .0001) (Figure 11 ; Table 4 ). Comparison of lower eyelid ecchymosis on PD 1 (P < .0001) and PD 7 (P < .0001) demonstrated a statistically significant decrease in severity in patients receiving extended dosing of steroids ( Figure 12 ; Table 4 ). 
disCussiOn
The periorbital area is especially prone to postoperative edema and bruising that can be difficult for the patient to camouflage. Intraoperative rhinoplasty maneuvers often cause significant postoperative periorbital morbidity, including palpebral edema that can result in temporary obstruction of vision. Furthermore, periorbital bruising can be visually disturbing and frightening to patients and families and can lead to permanent pigmentation of surrounding skin. 11 To minimize these postoperative conditions, many surgeons have attempted different preventative measures. Some have suggested hypotensive general anesthesia as a way to address these issues, 35 while others argue that this may actually increase the amount of ecchymosis, as appropriate intraoperative hemostasis may not be obtained. 36 Still others have evaluated intravenous administration of steroids and other agents.
Perioperative administration of corticosteroids has been shown to decrease both edema and ecchymosis in several studies. Other studies have shown no benefit. In the present meta-analysis, four trials that met previously-described inclusion criteria were identified and studied for outcomes after perioperative steroid administration. Many different steroid preparations and dosage schedules have been utilized in rhinoplasty patients. In addition, lack of standard evaluation of postoperative edema and bruising complicates comparison among groups in different studies. However, the studies reviewed here were consistent in their scale of postoperative evaluation. An overall analysis of pooled data from four trials therefore supports these suggestions and yields greater evidence for treatment guidelines for steroid administration in rhinoplasty patients.
Our review confirms that there is decreased upper and lower eyelid ecchymosis and edema after perioperative administration of steroids when compared to no intervention. These results reached statistical significance at PD 1 and 7. Three of the four studies reviewed utilized between 8 and 10 mg of dexamethasone intravenously, while the final review studied methylprednisolone. We were unable to determine a benefit of one particular steroid over another in the meta-analysis, but due to ease of dosing, dexamethasone continues to be the steroid of choice. The timing of steroid administration has also been a topic of concern for many rhinoplasty surgeons. Many believe that circulating steroids before osteotomy minimizes the degree of bruising and edema, when compared to administration in the recovery room. Our data would support this common notion. This benefit was lost, however, in upper and lower eyelid edema as well as in lower eyelid ecchymosis by PD 7. Finally, this meta-analysis suggests that, in addition to a preoperative dose, patients have a significant reduction in swelling and bruising when steroids are continued for up to three days. In our clinic, most patients are treated with an initial preoperative intravenous dose followed by redosing on PD 1 and 2 or discharge with oral prednisone taper over two days. This method can offer the best possible outcome for the occasional patient who requires earlier reintroduction to work or society events. Most patients undergoing rhinoplasty at our institution are discharged home from the recovery room; thus, for ease of treatment, oral steroids are preferred if at-home postoperative steroid administration is to continue.
Steroid administration is not always harmless and should not be given (especially for a prolonged period) without serious consideration of patient-specific medical factors. Prolonged steroid treatment should therefore be undertaken only when necessary and with the appropriate patient, after risk-benefit analysis. Complications such as gastrointestinal ulcer formation are usually seen in patients treated over the long term. 37 Consider, however, that metabolic changes and immunologic responses are altered in the postoperative period. 38 Metabolism of carbohydrates, lipids, and proteins is altered in the face of steroid treatment, especially affecting our diabetic patients. 39 Furthermore, mood changes secondary to steroid administration are well documented and can vary from depression to euphoria. 9 Of note, in the studies reviewed, there was a case of gastrointestinal bleeding in a patient treated with steroids for five days. 7 There are studies that have found no benefit with preoperative steroids in open rhinoplasty. Berinstein et al demonstrated that preoperative intravenous dexamethasone was associated with increased soft tissue edema, when evaluated by magnetic resonance imaging preoperatively and postoperatively. 8 The measurement of soft tissue thickness over the nasal bone-maxillary junction proved thicker in the steroid treatment group. The significance of this study is unknown and it was not analyzed in our meta-analysis due to the inability to compare the authors' postoperative definition of edema with our edema and ecchymosis scales. One of the studies included in this analysis demonstrated that betamethasone, dexamethasone, and methylprednisolone did not decrease postoperative edema. 11 This shows the utility of combining data sets, where possible, to further elucidate the answers to ongoing debate.
Other methods of minimizing swelling and bruising after facial surgery have been described. These methods include less traditional "herbal" medicines, such as papaya extract 40 and Melilotus extract, 41 in postrhinoplasty patient management. Totonchi and Guyuron conducted a prospective randomized trial to evaluate the difference in efficacy between arnica and steroids for control of postoperative swelling and bleeding. 12 They were found to be equally effective in reducing swelling in the early postoperative period, but arnica did not reduce ecchymosis while steroid treatment did.
Unfortunately, we were unable to differentiate between closed and open rhinoplasty because the discussed studies did not allow comparison. A comparison of the postoperative nasal edema seen after open and closed rhinoplasty would be a worthy investigation. Furthermore, there is clearly some subjectivity involved in the point-scale evaluation of edema and ecchymosis, which is why only trials that included blinded evaluation of patient outcomes were chosen. The nature of these evaluations lends itself to lowered interrater reliability. Finally, note that there is an inherent subjectivity in analyzing results from plastic surgery. The aesthetic nature of our specialty means that every patient is truly different and every procedure presents a unique challenge, which may lead to some decrease in reliability when data between patients and surgeons are compared.
COnCLusiOns
Based on our meta-analysis of existing randomized, prospective trials, patients who were given steroids had reduced edema and ecchymosis when compared with control patients who did not receive them. The overall data analysis confirms a statistically significant benefit when steroids are given in the preoperative period (either in preoperative holding or upon induction). Further, there is clearly a trend toward long-term reduction in edema and bruising if steroid treatment is continued in the postoperative period for three days. For this reason, patients who must return to work or social engagements in the early postoperative period (prior to Day 10) may benefit from continuing oral steroids at home to minimize postoperative edema and ecchymosis. Reinforced by these data-based guidelines, it is our practice to give 10 mg of dexamethasone in the preoperative area or upon induction. In a select group, we consider continuation of oral prednisone, 50 mg and 25 mg, on Postoperative Day 2 and Day 3, respectively. Ultimately, our review suggests that all patients have significant resolution of both edema and ecchymosis, regardless of treatment, by Day 10 postoperatively.
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